← FDA Drug Approvals (Drugs@FDA)

OMEPRAZOLE AND SODIUM BICARBONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANDA REPOSITORY · Approved 2020-04-30

Drug application

FDA Application #
ANDA212587
Application type
Abbreviated New Drug Application (Generic)
Brand name
OMEPRAZOLE AND SODIUM BICARBONATE
Generic name
OMEPRAZOLE, SODIUM BICARBONATE
Active ingredients
OMEPRAZOLE; SODIUM BICARBONATE
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
ANDA REPOSITORY
Manufacturer
Guardian Drug Company
First approval
2020-04-30

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown